Evidence map›Paper›PMID 36009940›Full record

ArticleAntibiotics (Basel, Switzerland)2022

High Fecal Prevalence of

Maryse Michèle Um, Véronique Dupouy, Nathalie Arpaillange, Clémence Bièche-Terrier, Frédéric Auvray, Eric Oswald, Hubert Brugère, Delphine Bibbal

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maryse Michèle UmInstitut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, 31 000 Toulouse, France.
Véronique DupouyInnovations Thérapeutiques et Résistances, Université de Toulouse, INRAE, ENVT, 31 000 Toulouse, France.ORCID 0000-0003-2059-9068
Nathalie ArpaillangeInnovations Thérapeutiques et Résistances, Université de Toulouse, INRAE, ENVT, 31 000 Toulouse, France.
Clémence Bièche-TerrierInstitut de l'Elevage, 75 012 Paris, France.
Frédéric AuvrayInstitut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, 31 000 Toulouse, France.ORCID 0000-0001-5532-1045
Eric OswaldInstitut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, 31 000 Toulouse, France.ORCID 0000-0002-3017-0081
Hubert BrugèreInstitut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, 31 000 Toulouse, France.ORCID 0000-0001-9256-0862
Delphine BibbalInstitut de Recherche en Santé Digestive, Université de Toulouse, INSERM, INRAE, ENVT, UPS, 31 000 Toulouse, France.ORCID 0000-0002-1070-4066
Université Toulouse III - Paul Sabatier · FRÉcole Nationale Vétérinaire de Toulouse · FRInstitut de l’Elevage · FR

Funding

French Ministry of Agriculture and Food French Ministry of Agriculture and Food
6 · The paper itself

Abstract

The aim of this study was to determine the percentage of healthy veal calves carrying

Indexed as

colistincritically important antibioticsEscherichia coliextended spectrum β-lactamasehealthy veal calvesmcr genes

Identifiers

PMID36009940
PMCPMC9405437
OpenAlexW4290703915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.